Internal Medicine, Endocrinology, Diabetes, & Metabolism · Rochester Hills, MI
NPI
1841245263
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1701 South Blvd E Ste 190
Rochester Hills, MI, 48307
Phone (586) 580-0760
Groups this clinician bills Medicare through
Medicare paid, 2024
$470K
7,805 services
Medicare patients, 2024
1,350
Average age 74
Drug cost, 2024
$3.2M
7,832 prescriptions
Company payments, 2025
$2,190
From 31 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Farah R Dawood-Farah was code 99232 (hospital e&m - subsequent), 3,487 times for 614 patients. In total Farah R Dawood-Farah billed 7,805 services in 17 codes, and Medicare paid $470K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-08-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 3,487 | 614 | $62.62 | $218K |
| 99214 Office E&M - Established | Office | 1,279 | 590 | $91.64 | $117K |
| 83036 Blood Count | Office | 673 | 333 | $9.17 | $6,169 |
| 82962 Clinical Chemistry | Office | 512 | 273 | $3.14 | $1,606 |
| 95251 Test - Miscellaneous | Office | 440 | 176 | $25.38 | $11K |
| 99222 Hospital E&M - Initial | Facility | 413 | 350 | $103.91 | $43K |
| 36415 Venipuncture Blood Collection | Office | 387 | 258 | $8.50 | $3,289 |
| 99223 Hospital E&M - Initial | Facility | 284 | 251 | $136.33 | $39K |
| 99204 Office E&M - New | Office | 122 | 122 | $122.09 | $15K |
| 99233 Hospital E&M - Subsequent | Facility | 86 | 72 | $93.91 | $8,076 |
| 99213 Office E&M - Established | Office | 62 | 53 | $67.25 | $4,170 |
| 99442 Telephone Services | Office | 31 | 26 | $68.32 | $2,118 |
| 95249 Test - Miscellaneous | Office | 12 | 12 | $43.58 | $523 |
By year: 2022 $608K for 10,043 services; 2023 $535K for 8,722 services; 2024 $470K for 7,805 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 673 | 333 | $9.17 | $6,169 |
| 82962 Clinical Chemistry | 512 | 273 | $3.14 | $1,606 |
| 36415 Venipuncture Blood Collection | 387 | 258 | $8.50 | $3,289 |
Medicare prescription drug claims, 2024
In 2024, the drug Farah R Dawood-Farah prescribed most often to Medicare patients was Levothyroxine Sodium, with 786 prescriptions and refills. In total Farah R Dawood-Farah wrote 7,832 Medicare prescriptions that cost $3.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 786 | 1,845 | 224 | $9,709 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 465 | 1,230 | 170 | $74K |
| Metformin Hcl Generic | 447 | 943 | 125 | $11K |
| Methimazole Generic | 435 | 896 | 109 | $5,258 |
| Jardiance Empagliflozin | 385 | 770 | 117 | $429K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 357 | 821 | 145 | $43K |
| Ozempic Semaglutide | 343 | 548 | 87 | $505K |
| Novolog Flexpen Insulin Aspart | 280 | 595 | 115 | $151K |
| Trulicity Dulaglutide | 245 | 342 | 59 | $326K |
| Januvia Sitagliptin Phosphate | 225 | 477 | 63 | $251K |
| Novolin 70-30 Flexpen Insulin Nph Hum/Reg Insulin Hm | 218 | 417 | 71 | $44K |
| Humulin 70/30 Kwikpen Insulin Nph Hum/Reg Insulin Hm | 201 | 381 | 52 | $56K |
| Humalog Kwikpen U-100 Insulin Lispro | 195 | 390 | 75 | $88K |
| Repaglinide Generic | 187 | 420 | 58 | $8,976 |
| Mounjaro Tirzepatide | 175 | 255 | 45 | $265K |
Brand drugs: 4,146 claims; generic drugs: 2,375 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Farah R Dawood-Farah $2,190 ($2,190 in general payments such as food, travel and fees) from 31 companies. The largest payer was Novo Nordisk Inc with $302.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 15 | $302 |
| Amgen Inc. AMGN | 21 | $280 |
| Abbott Laboratories ABT | 22 | $273 |
| Ascendis Pharma Endocrinology Inc ASND | 2 | $152 |
| Corcept Therapeutics CORT | 5 | $118 |
| Abbvie Inc. ABBV | 6 | $117 |
| Xeris Pharmaceuticals, Inc. | 4 | $92.73 |
| Ascensia Diabetes Care Us Inc. | 5 | $88.02 |
| Lilly USA, LLC LLY | 4 | $73.73 |
| Amneal Pharmaceuticals LLC AMRX | 3 | $58.92 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.